Intrahost viral evolution of SARS-CoV-2 infections in rheumatic versus hematological patients with severe iatrogenic immunosuppression - Summary - MDSpire
Advertisement
Intrahost viral evolution of SARS-CoV-2 infections in rheumatic versus hematological patients with severe iatrogenic immunosuppression
To investigate ongoing SARS-CoV-2 replication and intrahost genomic divergence in severely immunocompromised patients with rheumatic and hematological conditions, highlighting the significance of these findings for treatment strategies.
Key Findings:
85% of patients were hospitalized with a 23% mortality rate, indicating severe outcomes in this population.
Unique mutations were found in the spike gene, with a prevalence of < 0.1%, which may have implications for vaccine efficacy.
A statistically significant accumulation of iSNVs was observed, with an average substitution rate of 7 × 10–6 per site per day (p < 0.001), suggesting rapid viral evolution.
No significant difference in substitution rates was found between rheumatic and hematologic patients, indicating similar viral behavior in these groups.
Interpretation:
The study highlights the risk of prolonged SARS-CoV-2 replication in immunocompromised patients, leading to unique mutations and potential immune escape.
Limitations:
Small sample size may limit generalizability.
Mutations with low prevalence may not be clinically significant.
The observational nature of the study may introduce biases.
Conclusion:
A significant proportion of patients experienced relapsing COVID-19, with unique mutations primarily in the spike gene and a correlation between infection duration and iSNVs accumulation, which may inform future treatment strategies.
A retrospective cohort study of more than 520,000 hospitalized patients found no clinically meaningful improvement in deterioration or mortality with early treatment targeting community-acquired pneumonia.
